Baluch Khoso 4
4 · Processa Pharmaceuticals, Inc. · Filed Jul 24, 2023
Insider Transaction Report
Form 4
Baluch Khoso
Director
Transactions
- Exercise/Conversion
Restricted Stock
2023-06-27−15,455→ 0 totalExercise: $0.00→ Common Stock (15,455 underlying) - Award
Restricted Stock
2023-06-27+101,365→ 101,365 totalExercise: $0.00→ Common Stock (101,365 underlying) - Exercise/Conversion
Common Stock
2023-06-27+15,455→ 27,955 total
Footnotes (2)
- [F1]Vesting of time-based restricted shares.
- [F2]The restricted stock vests on the earliest of one year from date of grant or the next annual meeting of stockholders.